Meetings to be held April 8-9 hosted by Maxim.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MBRX:
- Moleculin Biotech files to sell 6.37M shares of common stock for holders
- Moleculin Biotech announces enrollment milestone in MIRACLE trial
- Moleculin Advances MIRACLE Trial, Prepares Interim AML Readout
- Moleculin Biotech: Attractive Risk/Reward Ahead of Pivotal Annamycin Phase 3 Readout Supports Buy Rating and $10 Target
- Moleculin Biotech Updates Investors with New Corporate Presentation